Understanding Mucormycoses in the Age of "omics".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

1. Understanding the biology of mucormycosis using contemporary omics tools: a review.Biotechnologia · 2026
   Review
2. Angioinvasion severity and admission GCS predict outcomes in invasive central nervous system fungal infections.Frontiers in cellular and infection microbiology · 2026
   Article
3. Calcium starvation leads to strain-specific gene regulation of lipid and carotenoid production in Mucor circinelloides.G3 (Bethesda, Md.) · 2025
   Article
4. Characterization of extracellular chitin deacetylase fromCurrent research in microbial sciences · 2025
   Article
5. Cutaneous mucormycosis with suspected dissemination in a patient with metastatic adrenocortical carcinoma.Medical mycology case reports · 2024
   Article
6. Mucormycosis: A Rare disease to Notifiable Disease.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
   Review
7. OMICS and Other Advanced Technologies in Mycological Applications.Journal of fungi (Basel, Switzerland) · 2023
   Review
8. Divergent Evolution of Early Terrestrial Fungi Reveals the Evolution of Mucormycosis Pathogenicity Factors.Genome biology and evolution · 2023
   Article
9. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
   Article
10. Next-Generation Sequencing Applications for the Study of Fungal Pathogens.Microorganisms · 2022
    Review
11. Transcontinental Dispersal of Nonendemic Fungal Pathogens through Wooden Handicraft Imports.mBio · 2022
    Article
12. The impact of SARS-CoV-2 on the sudden onset of Mucormycosis in the Indian subcontinent-A review.Journal of family medicine and primary care · 2022
    Review
13. Recent Advances and Future Directions in the Understanding of Mucormycosis.Frontiers in cellular and infection microbiology · 2022
    Review
14. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.Current fungal infection reports · 2022
    Review
15. Rhino-Orbital Cerebral Mucormycosis in a Patient With Diabetic Ketoacidosis: A Case Report and Literature Review.Frontiers in neurology · 2022
    Article
16. Mucormycosis.Infectious disease clinics of North America · 2021
    Review
17. NovelMycoKeys · 2021
    Article
18. Host-Pathogen Molecular Factors Contribute to the Pathogenesis ofCurrent tropical medicine reports · 2021
    Review
19. Pulmonary mucormycosis: A case report.IDCases · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as